Efficacy and Safety of Lurasidone in Children and Adolescents: Recommendations for Clinical Management and Future Research.

Volume: 27, Issue: 39, Pages: 4062 - 4069
Published: Jan 1, 2021
Abstract
Lurasidone is a novel azapirone derivative and atypical antipsychotic agent with a high binding affinity for dopaminergic (D2), serotoninergic (5-HT2A), and 5-HT7 receptors (antagonist), a moderate affinity for 5- HT1A receptors (partial agonist), and no appreciable affinity for histaminergic (H1) and muscarinic (M1) receptors. It was recently included by the European Medication Agency among the in-label pharmacological treatments for children...
Paper Details
Title
Efficacy and Safety of Lurasidone in Children and Adolescents: Recommendations for Clinical Management and Future Research.
Published Date
Jan 1, 2021
Volume
27
Issue
39
Pages
4062 - 4069
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.